Ładuje się......
Tumor Immunology and Immune Checkpoint Inhibitors in Non-Small Cell Lung Cancer
Lung cancer is one of the most commonly diagnosed cancers and the leading cause of cancer-related deaths worldwide. Although progress in the treatment of advanced non-small cell lung cancer (NSCLC) has been made over the past decade, the 5-year survival rate in patients with lung cancer remains only...
Zapisane w:
| Wydane w: | Tuberc Respir Dis (Seoul) |
|---|---|
| Główni autorzy: | , |
| Format: | Artigo |
| Język: | Inglês |
| Wydane: |
The Korean Academy of Tuberculosis and Respiratory Diseases
2018
|
| Hasła przedmiotowe: | |
| Dostęp online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5771744/ https://ncbi.nlm.nih.gov/pubmed/29332322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.4046/trd.2017.0120 |
| Etykiety: |
Dodaj etykietę
Nie ma etykietki, Dołącz pierwszą etykiete!
|